PMV Pharmaceuticals, Inc. (PMVP) Financials

PMVP Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 252.2 million 26.5 million
2023-09-30 261.0 million 23.4 million
2023-06-30 242.2 million 24.4 million
2023-03-31 254.0 million 23.8 million

PMVP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -12.3 million 3.0 million
2023-09-30 -15.7 million 3.3 million
2023-06-30 -13.5 million 3.2 million
2023-03-31 -15.2 million 2.9 million

PMVP Net Income

No data available :(

PMVP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 203.9 million - 13.3 million
2023-09-30 201.9 million - 12.7 million
2023-06-30 187.1 million - 13.0 million
2023-03-31 229.4 million - 13.5 million

PMVP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 51.4 million
2023-09-30 49.0 million
2023-06-30 45.8 million
2023-03-31 45.8 million

PMVP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 197000 13.0 million 5.5 million -
2023-09-30 44000 13.6 million 6.0 million -
2023-06-30 565000 13.8 million 6.3 million -
2023-03-31 156000 15.1 million 6.4 million -

PMVP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.6 million 359000
2023-09-30 - 358000
2023-06-30 - 369000
2023-03-31 - 82000

PMVP

Price: $1.87

52 week price:
1.18
9.72

Earnings Per Share: -1.44 USD

P/E Ratio: -1.14

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 230900

Market Capitalization: 82.3 million

Links: